| ROS | Reactive oxygen species |
| Prdxs | Peroxiredoxins |
| ATP | Adenosine triphosphate |
| SOD | Superoxide dismutase |
| Cys | Cysteine |
| Cp | Peroxidatic cysteine |
| Cr | Resolving cysteine |
| ERK | Extracellular signal related kinase |
| JNK | Jun N-terminal kinase |
| MAPK | Mitogen activated protein kinase |
| PTP | Protein tyrosine phosphatases |
| PTEN | Phosphatase and tensin homologues |
| CSCs | Cancerous stem cells |
| NRF2 | Nuclear factor erythroid 2 related factor |
| KEAP1 | Kelch like ECH associated proteins |
| AREs | Antioxidant responsive elements |
| HIFs | Hypoxia inducible factors |
| PHDs | Prolyl hydroxylases |
| pVHL | von Hippel-Laundau protein |
| CCRCC | Clear cell renal cell carcinoma |
| FOXM1 | Forkhead box protein 1 |
| LNCaP | Lymph node carcinoma of prostate |
| TIMP1 | TIMP metallopeptidase inhibitor 1 |
| ECM | Extracellular matrix |
| HepG2 | Human hepatocellular carcinoma/hepatoma cell lines |
| MCF-7 | Mitichigan cancer foundation-7 cancerous cell lines |
| HER2 | Human epithelial growth factor receptor 2 |
| Trx2 | Thioredoxin 2 |
| TrxR2 | Thioredoxin reductase 2 |
| Srx | Sulfiredoxin |
| MM | Malignant mesothelioma |
| NF-κB | Nuclear factor κB |
| ARE | Antioxidant responsive element |
| IRE | Insulin responsive element |
| GRE | Glucocorticoid responsive element |
| Ets ½ | E twenty six transcription factor 1 and 2 |
| HMGB1 | High mobility group protein B1 |